Sickle cell disease commonly affects people of African and Caribbean backgrounds and can be life-threatening but campaigners ...

(Reuters) -Gene therapy, with its offer of a possible cure for rare diseases like sickle cell, is losing early investors to ...

His eyes would turn yellow regularly due to ... You’re engineering those cells to recover from sickle cell disease and essentially fix the deficits that’s there. That in and of itself takes ...

The Long Island man had been coming to the hospital since he was 2 months old, now after 21 years he is cured. Read on to know how it happened.

Beam Therapeutics Inc.’s BEAM share price has dipped by 11.15%, which has investors questioning if this is right time to buy.

The competition between U.S. and Chinese biotech companies is particularly fierce in one field: CRISPR gene editing. Here are ...

A pair of privately-held developers of editing-based therapies have some successes to show for their recent efforts to ...

Learn more about whether Alvotech or CRISPR Therapeutics AG is a better investment based on AAII's A+ Investor grades, which ...

Over the decades shows like Star Trek, Doctor Who and Battlestar Galactica have picked up loyal audiences. In more recent ...

RNA-based therapeutics are gaining traction due to advancements in delivery technologies, despite historical challenges with ...